How cyclodextrins can mask their toxic effect on the blood-brain barrier

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 7, 2006, Pages 1784-1787

  Binkowski Machut, Cécile ^a   Hapiot, Frédéric ^a   Martin, Patrick ^a   Cecchelli, Roméo ^a   Monflier, Eric ^a  

^a UNIVERSITÉ D'ARTOIS   (France)

Author keywords

Blood brain barrier; Cyclodextrins; Endothelial cells; In vitro model; Permeability; Toxicity

Indexed keywords

BETA CYCLODEXTRIN DERIVATIVE; CYCLODEXTRIN DERIVATIVE;

ARTICLE; BLOOD BRAIN BARRIER; CYTOTOXICITY; DRUG STRUCTURE; ENDOTHELIUM CELL; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY;

BLOOD-BRAIN BARRIER; CYCLODEXTRINS;

EID: 33144457514     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.01.031     Document Type: Article

References (15)

1. K. Uekama Adv. Drug Delivery Rev. 36 1999 1
2. M.K. Hristova-Kazmierski, P. Horan, P. Davis, H.I. Yamamura, T. Kramer, R. Horvath, W.M. Kazmierski, F. Porreca, and V.J. Hruby Bioorg. Med. Chem. 3 1993 831
3. F. Camargo, R.P. Erickson, W.S. Garver, G.S. Hossain, P.N. Carbone, R.A. Heidenreich, and J. Blanchard Life Sci. 70 2001 131
4. J. Pitha, A. Gerloczy, and A. Olivi J. Pharm. Sci. 83 1994 833
5. W.R. Anderson, J.W. Simpkins, M.E. Brewster, and N. Bodor Drug Des. Deliv. 2 1988 287
6. V. Monnaert, S. Tilloy, H. Bricout, L. Fenart, R. Cecchelli, and E. Monflier J. Pharmacol. Exp. Ther. 310 2004 745
7. C. Binkowski, F. Hapiot, V. Lequart, P. Martin, and E. Monflier Org. Biomol. Chem. 3 2005 1129
8. S.L. Hauser, E.W. Johanson, H.P. Green, and P.J. Smith Org. Lett. 2 2000 3575
9. I.W. Muderawan, T.-T. Ong, W.-h. Tang, D.J. Young, C.-B. Ching, and S.-C. Ng Tetrahedron Lett. 46 2005 1747
10. R.C. Petter, J.S. Salek, C.T. Silorski, G. Kumaravel, and F.T. Lin J. Am. Chem. Soc. 112 1991 3860
11. Endothelial cells were prepared and coated on filters as previously described: M.P. Dehouck, P. Jolliet-Riant, F. Brée, J.C. Fruchart, R. Cecchelli, and J.P. Tillement J. Neurochem. 58 1992 1790
12. R. Cecchelli, B. Dehouck, L. Descamps, L. Fenart, V. Buée- Scherrer, C. Duhem, S. Lundquist, M. Rentfel, G. Torpier, and M.P. Dehouck Adv. Drug Delivery Rev. 36 1999 165
13. 10 by dividing the amount of compound in the receiver compartment by the drug concentration in the donor compartment at each time point. The average cumulative volume cleared was plotted versus time, and the slope was estimated by linear regression analysis to give the mean and standard deviation of the estimate. The slope of the clearance curve with inserts alone and inserts with BCEC monolayer is equal to PSf and PSt, respectively, where PS = the permeability surface area product. The units of PS and S are microlitres per minute and square centimetres, respectively. The PS value for endothelial monolayer (PSe) was obtained as follows: 1/PSe = 1/PSt - 1/PSf. To generate the endothelial permeability coefficient Pe (centimetres per minute), the PSe value was divided by the surface area of the insert. For the CDs, results were expressed as a percentage of transport across the BCEC monolayer alone and were obtained from the transport across the inserts coated with collagen and seeded with BCECs and the transport across the inserts coated only with collagen.
14. M.P. Dehouck, B. Dehouck, C. Schluep, M. Lemaire, and R. Cecchelli Eur. J. Pharm. Sci. 3 1995 357
15. A. Siflinger-Birnboim, P.J. Del Becchio, J.A. Cooper, F.A. Blumenstock, J.N. Shepard, and A.B. Malik J. Cell Physiol. 132 1987 111